![Colorectal Cancer Market](https://cdn.vantagemarketresearch.com/report/cover/Colorectal-Cancer-Market.webp)
Colorectal Cancer Market
Colorectal Cancer Market - Global Industry Assessment & Forecast
Segments Covered
By Therapy Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies
By Cancer Type Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Other Cancer Types
By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
![]() |
2023 |
![]() |
2024 - 2032 |
![]() |
2018 - 2022 |
![]() |
USD 11.9 Billion |
![]() |
USD 17.99 Billion |
![]() |
4.7% |
![]() |
Asia Pacific |
![]() |
North America |
Customization Offered
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst
Sr. No. | Offering | Report Coverage |
1. | Market Size | In terms of Revenue (USD Million) |
2. | Historic Data | 2018 to 2022 |
3. | Forecast Data | 2024 to 2032 |
4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
5. | Market Attractiveness Analysis | Yes |
6. | Segment Analysis | Maximum Segments |
7. | Regional Coverage | 5 Regions |
8. | Country Coverage | Top 22 Countries |
9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
10. | Porter’s Five Forces Analysis | Yes. |
11. | Value Chain Analysis | Yes |
12. | PEST Analysis | Yes |
13. | Regulatory Landscape | Yes |
14. | Technology Landscape | Yes |
15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
16. | Top startups to watch out for | Yes |
17. | Top 3 Trends to Watch | Yes |
18. | Top 3 Strategies Followed by Major Players | Yes |
19. | Top 3 Predictions by Vantage Market Research | Yes |
20. | Discussion Guide | Yes |
21. | Key Primary Respondents - VERBATIM | Yes |
22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
23. | Others/Miscellaneous |
FAQ
Frequently Asked Question
What is the global demand for Colorectal Cancer in terms of revenue?
-
The global Colorectal Cancer valued at USD 11.9 Billion in 2023 and is expected to reach USD 17.99 Billion in 2032 growing at a CAGR of 4.7%.
Which are the prominent players in the market?
-
The prominent players in the market are Eli Lilly and Company (U.S.), Genentech Inc. (U.S.), Ipsen Biopharmaceuticals Inc. (U.S.), Merck Sharp & Dohme Corp. (U.S.), Pfizer Inc. (U.S.), Bayer AG (Germany), Bristol Myers Squibb Company (U.S.), Regeneron Pharmaceuticals Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Taiho Pharmaceutical (Otsuka Pharmaceutical Co. Ltd.) (Japan), Novartis AG (Switzerland), Sanofi (France).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 4.7% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Colorectal Cancer include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Colorectal Cancer in 2023.